As of 2025-07-08, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.13) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -329.0%.
The range of the Relative Valuation is (0.93) - (1.32) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 10.7x | 9.0x |
| Forward P/E multiples | 7.6x - 11.4x | 9.5x |
| Fair Price | (0.93) - (1.32) | (1.13) |
| Upside | -288.7% - -366.6% | -329.0% |
| Date | P/E |